Evaluation of genotoxic potential of tert-butylquinone and its derivatives in prokaryotic and eukaryotic test models

References

• Aktas, N., et al., 2010. Avarone and Avarol from the Marine Sponge Dysidea avara Schmidt from Aegean Coast of Turkey. FABAD Journal of Pharmaceutical Sciences, 35, 119–123.
   Google Scholar
• Batke, E., et al., 1988. Action of the antileukemic and anti-HTLV-III (anti-HIV) agent avarol on the levels of superoxide dismutases and glutathione peroxidase activities in L5178y mouse lymphoma cells. Cell Biochemistry and Function, 6 (2), 123–129.
   PubMed Web of Science ®Google Scholar
• Bergmann, B., Dohrmann, J.K., and Kahl, R., 1992. Formation of the semiquinone anion radical from tert-butylquinone and from tert-butylhydroquinone in rat liver microsomes. Toxicology, 74 (2-3), 127–133.
   PubMed Web of Science ®Google Scholar
• Birnboim, H.C., 1983. A rapid alkaline extraction method for the isolation of plasmid DNA. Methods in Enzymology, 100, 243–255]
   PubMed Web of Science ®Google Scholar
• Božić, T., et al., 2010. Synthesis and biological activity of derivatives of the marine quinoneavarone. European Journal of Medicinal Chemistry, 45 (3), 923–929.
   PubMed Web of Science ®Google Scholar
• Česen, M., et al., 2016. Ecotoxicity and genotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and their mixtures. Environmental Pollution, 210, 192–201.
   PubMed Web of Science ®Google Scholar
• Ferrándiz, M.L., et al., 1994. Avarol and avarone, two new anti-inflammatory agents of marine origin. European Journal of Pharmacology, 253 (1-2), 75–82.
   PubMed Web of Science ®Google Scholar
• Hageman, G.J., Verhagen, H., and Kleinjans, J.C.S., 1988. Butylated hydroxyanisole, butylated hydroxytoluene and tert-butylhydroquinone are not mutagenic in the Salmonella microsome assay using new tester strains. Mutation Research, 208 (3-4), 207–211.
   PubMedGoogle Scholar
• Jeremić, M., et al., 2018. Alkylamino and aralkylamino derivatives of avarone and its mimetic as selective agents against non-small cell lung cancer cells, their antibacterial and antifungal potential. Journal of the Serbian Chemical Society, 83, 1–14.
   Web of Science ®Google Scholar
• Jeremić, M., et al., 2016. Simple avarone mimetics as selective agents against multidrug resistant cancer cells. European Journal of Medicinal Chemistry, 118, 107–120.
   PubMed Web of Science ®Google Scholar
• Kolarević, S., et al., 2018. Evaluation of genotoxic potential of avarol, avarone, and its methoxy and methylamino derivatives in prokaryotic and eukaryotic test models. Drug and Chemical Toxicology, 1–10. doi:10.1080/01480545.2017.1413108
   PubMed Web of Science ®Google Scholar
• Müller, W.E., et al., 1987. Avarol-induced DNA strand breakage in vitro and in Friend erythroleukemia cells. Cancer Research, 47, 6565–6571.
   PubMed Web of Science ®Google Scholar
• Nakamura, S., et al., 1987. SOS-inducing activity of chemical carcinogens and mutagens in Salmonella typhimurium TA1535/pSK 1002: examination with 151 chemicals. Mutation Research, 192 (4), 239–247.
   PubMedGoogle Scholar
• Novak, M., Hercog, K., and Žegura, B., 2016. Assessment of the mutagenic and genotoxic activity of cyanobacterial toxin beta-N-methyl-amino-L-alanine in Salmonella typhimurium. Toxicon, 118, 134–140.
   PubMed Web of Science ®Google Scholar
• Rogers, C.G., et al., 1993. Cytotoxic and genotoxic properties of tert-butyl-p-quinone (TBQ) in an in vitro assay system with Chinese hamster V79 cells and in strain D7 of Saccharomyces cerevisiae. Mutation Research, 299 (1), 9–18.
   PubMedGoogle Scholar
• Russo, A., et al., 2006. Genistin inhibits UV light-induced plasmid DNA damage and cell growth in human melanoma cells. The Journal of Nutritional Biochemistry, 17 (2), 103–108.
   PubMed Web of Science ®Google Scholar
• Shi, X., et al., 2014. 2-tert-butyl-1,4-benzoquinone induced apoptosis in chronic myeloid leukemia cells resistant to imatinib via inducing caspase-dependent Bcr-Abl downregulation. Medicinal Chemistry, 4, 786–790.
   Google Scholar
• Simmons, T.L., et al., 2005. Marine natural products as anticancer drugs. Molecular Cancer Therapeutics, 4, 333–342.
   PubMed Web of Science ®Google Scholar
• Sladić, D., and Gašić, M.J., 2006. Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida. Molecules, 11 (1), 1–33.
   PubMed Web of Science ®Google Scholar
• Tice, R.R., et al., 2000. Single cell gel/Comet Assay: guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis, 35 (3), 206–221.
   PubMed Web of Science ®Google Scholar
• Toolaram, A.P., Kümmerer, K., and Schneider, M., 2014. Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings. Mutation Research/Reviews, 760, 18–35.
   Web of Science ®Google Scholar
• Tsoukatou, M., et al., 2007. Evaluation of the activity of the sponge metabolites avarol and avarone and their synthetic derivatives against fouling micro- and macroorganisms. Molecules, 12 (5), 1022–1034.
   PubMed Web of Science ®Google Scholar
• Vilipić, J.P., et al., 2016. Interactions of cytotoxic amino acid derivatives of tert-butylquinone with DNA and lysozyme. Journal of the Serbian Chemical Society, 81 (12), 1345–1358.
   Web of Science ®Google Scholar
• Vujčić, M., et al., 2007. Interactions of the anti-tumor sesquiterpene hydroquinone avarol with DNA in vitro. Journal of the Serbian Chemical Society, 72 (12), 1265–1269.
   Web of Science ®Google Scholar
• World Health Organization (WHO), 2018. http://www.who.int/news-room/fact-sheets/detail/cancer.
   Google Scholar